{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:00:03Z","timestamp":1789398003620,"version":"build-2803163510"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T00:00:00Z","timestamp":1721260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Contrast-enhanced breast magnetic resonance imaging (MRI) is currently recommended as a screening tool for high-risk women and has been advocated for women with radiologically dense breast tissue. While breast MRI is acknowledged for its high sensitivity (with an exception for lower-grade ductal carcinoma <jats:italic>in situ<\/jats:italic> (DCIS) where emerging techniques like diffusion-weighted imaging offer improvement), its limitations include sensitivity to hormonal changes and a relatively high false-positive rate, potentially leading to overdiagnosis, increased imaging uncertainty, and unnecessary biopsies. These factors can exacerbate patient anxiety and impose additional costs. Molecular imaging with breast-targeted Positron Emission Tomography (PET) has shown the capability to detect malignancy independent of breast density and hormonal changes. Furthermore, breast-targeted PET has shown higher specificity when compared with MRI. However, traditional PET technology is associated with high radiation dose, which can limit its widespread use particularly in repeated studies or for undiagnosed patients. In this case report, we present a clinical application of low-dose breast imaging utilizing a breast-targeted PET camera (Radialis PET imager, Radialis Inc). The case involves a 33-year-old female patient who had multiple enhanced lesions detected on breast MRI after surgical removal of a malignant phyllodes tumor from the right breast. A benign core biopsy was obtained from the largest lesion seen in the left breast. One month after the MRI, 18F-fluorodeoxyglucose (<jats:sup>18<\/jats:sup>F-FDG) PET imaging session was performed using the Radialis PET Imager. Although the Radialis PET Imager has proven high count sensitivity and the capability to detect breast lesions with low metabolic activity (at a dose similar to mammography), no areas of increased <jats:sup>18<\/jats:sup>F-FDG uptake were visualized in this particular case. The patient underwent a right-sided nipple-sparing mastectomy and left-sided lumpectomy, with bilateral reconstruction. The excised left breast tissue was completely benign, as suggested by both core biopsy and the PET results. The case presented highlights a promising clinical application of low-dose breast-targeted PET imaging to mitigate the uncertainty associated with MRI while keeping radiation doses within the safe range typically used in X-ray mammography.<\/jats:p>","DOI":"10.3389\/fonc.2024.1405404","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T04:53:15Z","timestamp":1721278395000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case report: Possible role of low-dose PEM for avoiding unneeded procedures associated with false-positive or equivocal breast MRI results"],"prefix":"10.3389","volume":"14","author":[{"given":"Madeline","family":"Rapley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivianne","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irving N.","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Baldassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harutyun","family":"Poladyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Waterston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Ghai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Taeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleksandr","family":"Bubon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Marie","family":"Mulligan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alla","family":"Reznik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/jmri.26985","article-title":"Role of breast MRI in the evaluation and detection of DCIS: opportunities and challenges","volume":"52","author":"Greenwood","year":"2020","journal-title":"J Magn Reson Imaging"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.0839","article-title":"Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial","volume":"28","author":"Kuhl","year":"2010","journal-title":"J Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903986","article-title":"Supplemental MRI screening for women with extremely dense breast tissue","volume":"381","author":"Bakker","year":"2019","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djz130","article-title":"Breast cancer screening in high-risk women: is MRI alone enough","volume":"112","author":"Saccarelli","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.8674","article-title":"Current status of supplemental screening in dense breasts","volume":"34","author":"Berg","year":"2016","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmir.2022.03.072","article-title":"Breast MRI: Where are we currently standing","volume":"53","author":"Bougias","year":"2022","journal-title":"J Med Imaging Radiat Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.mric.2017.12.006","article-title":"Use of breast-specific PET scanners and comparison with MR imaging","volume":"26","author":"Narayanan","year":"2018","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000033146","article-title":"Magnetic resonance imaging in screening women at high risk of breast cancer: A meta-analysis","volume":"102","author":"Ding","year":"2023","journal-title":"Med (Baltimore)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s12149-021-01582-y","article-title":"Clinical practice guidelines for high-resolution breast PET, 2019 edition","volume":"35","author":"Satoh","year":"2021","journal-title":"Ann Nucl Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.14.13357","article-title":"Molecular breast imaging at reduced radiation dose for supplemental screening in mammographically dense breasts","volume":"204","author":"Rhodes","year":"2015","journal-title":"AJR Am J Roentgenol"},{"key":"B11","doi-asserted-by":"crossref","DOI":"10.1109\/ISBI.2004.1398808","article-title":"Applications of a PET device with 1.5 mm FWHM intrinsic spatial resolution to breast cancer imaging","author":"Weinberg","year":"2004"},{"key":"B12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1177\/153303460500400108","article-title":"Positron emission mammography: high-resolution biochemical breast imaging","volume":"4","author":"Weinberg","year":"2005","journal-title":"Technol Cancer Res Treat"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S1120-1797(06)80045-1","article-title":"Applications for positron emission mammography","volume":"21","author":"Weinberg","year":"2006","journal-title":"Phys Med Eur J Med Phys"},{"key":"B14","doi-asserted-by":"publisher","first-page":"21930","DOI":"10.1038\/s41598-020-78865-3","article-title":"Evaluation of primary breast cancers using dedicated breast PET and whole-body PET","volume":"10","author":"Hathi","year":"2020","journal-title":"Sci Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01301","article-title":"Progress and future trends in PET\/CT and PET\/MRI molecular imaging approaches for breast cancer","volume":"10","author":"Ming","year":"2020","journal-title":"Front Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpet.2018.02.008","article-title":"Dedicated breast gamma camera imaging and breast PET: current status and future directions","volume":"13","author":"Narayanan","year":"2018","journal-title":"PET Clin"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2013.12.004","article-title":"Diagnostic performance of dedicated positron emission mammography using fluorine-18-fluorodeoxyglucose in women with suspicious breast lesions: a meta-analysis","volume":"14","author":"Caldarella","year":"2014","journal-title":"Clin Breast Cancer"},{"key":"B18","article-title":"Frost & Sullivan names naviscan a leader in the future of molecular breast imaging","author":"Chong","year":"2009","journal-title":"Cancer Wkly"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.230020","article-title":"Breast cancer detection using a low-dose positron emission digital mammography system","volume":"6","author":"Freitas","year":"2024","journal-title":"Radiology: Imaging Cancer"},{"key":"B20","volume-title":"Evaluating Positron Emission Mammography Imaging of Suspicious Breast Abnormalities","year":""},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacr.2015.07.001","article-title":"Curies, and grays, and sieverts, oh my: A guide for discussing radiation dose and risk of molecular breast imaging","volume":"12","author":"Hruska","year":"2015","journal-title":"J Am Coll Radiol JACR"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/s22134678","article-title":"Evaluation of a high-sensitivity organ-targeted PET camera","volume":"22","author":"Stiles","year":"2022","journal-title":"Sensors"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.240006","article-title":"Low-dose positron emission mammography: A novel, promising technique for breast cancer detection","volume":"6","author":"Barreto","year":"2024","journal-title":"Radiology: Imaging Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4103\/0971-5916.174563","article-title":"Estimation of radiation dose to patients from 18FDG whole body PET\/CT investigations using dynamic PET scan protocol","volume":"142","author":"Kaushik","year":"2015","journal-title":"Indian J Med Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.4065\/mcp.2010.0260","article-title":"Radiation risk from medical imaging","volume":"85","author":"Lin","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"B26","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/jbi\/wbaa016","article-title":"Radiation doses and risks in breast screening","volume":"2","author":"Hendrick","year":"2020","journal-title":"J Breast Imaging"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.2019190070","article-title":"Let\u2019s get real about molecular breast imaging and radiation risk","volume":"1","author":"Hruska","year":"2019","journal-title":"Radiol Imaging Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1148\/rg.230051","article-title":"Imaging and management of fibroepithelial lesions of the breast: radiologic-pathologic correlation","volume":"43","author":"Zhang","year":"2023","journal-title":"RadioGraphics"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S215039","article-title":"Phyllodes tumor of the breast: diagnosis, management and outcome during a 10-year experience","volume":"11","author":"Ditsatham","year":"2019","journal-title":"Cancer Manag Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12885-023-11805-2","article-title":"Margin status impact on recurrence of phyllodes tumors in high-risk groups: A retrospective observational study","volume":"24","author":"Ranjbar","year":"2024","journal-title":"BMC Cancer"}],"updated-by":[{"DOI":"10.3389\/fonc.2024.1477862","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000}}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1405404\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T12:56:40Z","timestamp":1727269000000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1405404\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,18]]},"references-count":30,"alternative-id":["10.3389\/fonc.2024.1405404"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1405404","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fonc.2024.1477862","asserted-by":"object"}]},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,18]]},"article-number":"1405404"}}